Table of Content

Table of Contents

1. Executive Summary

2. Global Biomarker Test Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031
3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Biomarker Test Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Biomarker Test Market by Application
3.3.1: Cancer
3.3.2: Cardiovascular
3.3.3: Infectious Diseases
3.3.4: Central Nervous Systems
3.3.5: Others
3.4: Global Biomarker Test Market by End Use
3.4.1: Pharma & Biotech Companies
3.4.2: Diagnostic Tools Companies
3.4.3: Healthcare IT/ Big Data Companies
3.4.4: Clinical Laboratories
3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031
4.1: Global Biomarker Test Market by Region
4.2: North American Biomarker Test Market
4.2.1: North American Market by Application: Cancer, Cardiovascular, Infectious Diseases, Central Nervous Systems, and Others
4.2.2: North American Market by End Use: Pharma & Biotech Companies, Diagnostic Tools Companies, Healthcare IT/ Big Data Companies, Clinical Laboratories, and Others
4.3: European Biomarker Test Market
4.3.1: European Market by Application: Cancer, Cardiovascular, Infectious Diseases, Central Nervous Systems, and Others
4.3.2: European Market by End Use: Pharma & Biotech Companies, Diagnostic Tools Companies, Healthcare IT/ Big Data Companies, Clinical Laboratories, and Others
4.4: APAC Biomarker Test Market
4.4.1: APAC Market by Application: Cancer, Cardiovascular, Infectious Diseases, Central Nervous Systems, and Others
4.4.2: APAC Market by End Use: Pharma & Biotech Companies, Diagnostic Tools Companies, Healthcare IT/ Big Data Companies, Clinical Laboratories, and Others
4.5: ROW Biomarker Test Market
4.5.1: ROW Market by Application: Cancer, Cardiovascular, Infectious Diseases, Central Nervous Systems, and Others
4.5.2: ROW Market by End Use: Pharma & Biotech Companies, Diagnostic Tools Companies, Healthcare IT/ Big Data Companies, Clinical Laboratories, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Biomarker Test Market by Application
6.1.2: Growth Opportunities for the Global Biomarker Test Market by End Use
6.1.3: Growth Opportunities for the Global Biomarker Test Market by Region
6.2: Emerging Trends in the Global Biomarker Test Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Biomarker Test Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Test Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: Hoffmann-La Roche
7.2: Novartis
7.3: Pfizer
7.4: GlaxoSmithKline
7.5: GE Healthcare
7.6: Medtronic
7.7: Quest Diagnostics